Results 251 to 260 of about 63,889 (276)

Remicade (Infliximab)

Gastroenterology Nursing, 1998
openaire   +2 more sources

Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease

Journal of Crohn's and Colitis, 2013
Arnošt Komárek, Milan Lukas, Martin Bortlik   +2 more
exaly  

<p>Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events</p>

Drug Design, Development and Therapy, 2019
Yuling Shi, Youdong Chen
exaly  

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer

Annals of Oncology, 2008
D Propper, J F Smyth, F R Balkwill
exaly  

Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment

Journal of Crohn's and Colitis, 2014
Jakob Nilsson, Michael Eberhardson, Ulf Sundin   +2 more
exaly  

Infliximab

Reactions Weekly, 2018
  +4 more sources

Trough Levels and Antibodies to Infliximab May Not Predict Response to Intensification of Infliximab Therapy in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Diseases, 2012
Benjamin Pariente, Matthieu Allez, Pierre Desreumaux   +2 more
exaly  

Infliximab

Reactions Weekly, 2020
openaire   +1 more source

Clinical outcomes in sarcoidosis after cessation of infliximab treatment

Respirology, 2009
Marc Judson
exaly  

Infliximab

Reactions Weekly
  +4 more sources